Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 932-941

  Nishida, Keigo ^a,b   Yamasaki, Satoru ^a   Hasegawa, Aiko ^a,c   Iwamatsu, Akihiro ^a,d   Koseki, Haruhiko ^a   Hirano, Toshio ^a,c  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Protein Research Network Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; IMMUNOGLOBULIN E RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN GAB2; PROTEIN KINASE FYN; PROTEIN TYROSINE PHOSPHATASE SHP; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL GRANULE; CONTROLLED STUDY; CYTOKINE PRODUCTION; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

ADP-RIBOSYLATION FACTOR 1; ANAPHYLAXIS; ANIMALS; BINDING SITES; BONE MARROW CELLS; CELL DEGRANULATION; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; CYTOPLASMIC GRANULES; DOWN-REGULATION; GENE KNOCK-IN TECHNIQUES; MAST CELLS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PROTEIN TRANSPORT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RECEPTORS, IGE;

EID: 79960508390     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100360     Document Type: Article

References (50)

1. Metz, M., M. A. Grimbaldeston, S. Nakae, A. M. Piliponsky, M. Tsai, and S. J. Galli. 2007. Mast cells in the promotion and limitation of chronic in- flammation. Immunol. Rev. 217: 304-328.
2. Galli, S. J., M. Tsai, and A. M. Piliponsky. 2008. The development of allergic inflammation. Nature 454: 445-454.
3. Kawakami, T., T. Ando, M. Kimura, B. S. Wilson, and Y. Kawakami. 2009. Mast cells in atopic dermatitis. Curr. Opin. Immunol. 21: 666-678.
4. Rivera, J., and A. Olivera. 2008. A current understanding of Fc epsilon RIdependent mast cell activation. Curr. Allergy Asthma Rep. 8: 14-20.
5. Gu, H., J. C. Pratt, S. J. Burakoff, and B. G. Neel. 1998. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol. Cell 2: 729-740.
6. Nishida, K., Y. Yoshida, M. Itoh, T. Fukada, T. Ohtani, T. Shirogane, T. Atsumi, M. Takahashi-Tezuka, K. Ishihara, M. Hibi, and T. Hirano. 1999. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and Tand B-cell antigen receptors. Blood 93: 1809-1816. (Pubitemid 29128480)
7. Zhao, C., D. H. Yu, R. Shen, and G. S. Feng. 1999. Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1. J. Biol. Chem. 274: 19649-19654.
8. Nishida, K., and T. Hirano. 2003. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci. 94: 1029-1033. (Pubitemid 38035515)
9. Gu, H., and B. G. Neel. 2003. The "Gab" in signal transduction. Trends Cell Biol. 13: 122-130.
10. Gu, H., K. Saito, L. D. Klaman, J. Shen, T. Fleming, Y. Wang, J. C. Pratt, G. Lin, B. Lim, J. P. Kinet, and B. G. Neel. 2001. Essential role for Gab2 in the allergic response. Nature 412: 186-190.
11. Nishida, K., S. Yamasaki, Y. Ito, K. Kabu, K. Hattori, T. Tezuka, H. Nishizumi, D. Kitamura, R. Goitsuka, R. S. Geha, et al. 2005. FcepsilonRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 170: 115-126. (Pubitemid 40994101)
12. Yu, M., C. A. Lowell, B. G. Neel, and H. Gu. 2006. Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI. J. Immunol. 176: 2421-2429. (Pubitemid 43201692)
13. Chan, J. H., W. Liao, H. Y. Lau, and W. S. Wong. 2007. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions. Int. Immunopharmacol. 7: 937-944.
14. Huang, F., X. Tong, H. Deng, L. Fu, and R. Zhang. 2008. Inhibition of the antigen-induced activation of RBL-2H3 cells by Gab2 siRNA. Cell. Mol. Immunol. 5: 433-438.
15. Yu, M., J. Luo, W. Yang, Y. Wang, M. Mizuki, Y. Kanakura, P. Besmer, B. G. Neel, and H. Gu. 2006. The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J. Biol. Chem. 281: 28615-28626.
16. Sulimenko, V., E. Dráberová, T. Sulimenko, L. Macurek, V. Richterová, P. Dráber, and P. Dráber. 2006. Regulation of microtubule formation in activated mast cells by complexes of gamma-tubulin with Fyn and Syk kinases. J. Immunol. 176: 7243-7253. (Pubitemid 43849024)
17. Liu, Y., M. Zhu, K. Nishida, T. Hirano, and W. Zhang. 2007. An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response. J. Exp. Med. 204: 93-103.
18. Hong, H., J. Kitaura, W. Xiao, V. Horejsi, C. Ra, C. A. Lowell, Y. Kawakami, and T. Kawakami. 2007. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 110: 2511-2519. (Pubitemid 47523173)
19. Kabu, K., S. Yamasaki, D. Kamimura, Y. Ito, A. Hasegawa, E. Sato, H. Kitamura, K. Nishida, and T. Hirano. 2006. Zinc is required for Fc epsilon RI-mediated mast cell activation. J. Immunol. 177: 1296-1305. (Pubitemid 44036636)
20. Hirano, T., M. Murakami, T. Fukada, K. Nishida, S. Yamasaki, and T. Suzuki. 2008. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv. Immunol. 97: 149-176.
21. Roth, M. G. 1999. Snapshots of ARF1: implications for mechanisms of activation and inactivation. Cell 97: 149-152. (Pubitemid 29194264)
22. Jackson, C. L., and J. E. Casanova. 2000. Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. Trends Cell Biol. 10: 60-67.
23. Randazzo, P. A., and D. S. Hirsch. 2004. Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling. Cell. Signal. 16: 401-413.
24. D'Souza-Schorey, C., and P. Chavrier. 2006. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7: 347-358.
25. Nishida, K., L. Wang, E. Morii, S. J. Park, M. Narimatsu, S. Itoh, S. Yamasaki, M. Fujishima, K. Ishihara, M. Hibi, et al. 2002. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 99: 1866-1869. (Pubitemid 34533066)
26. Itoh, S., M. Itoh, K. Nishida, S. Yamasaki, Y. Yoshida, M. Narimatsu, S. J. Park, M. Hibi, K. Ishihara, and T. Hirano. 2002. Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. J. Immunol. 168: 5110-5116. (Pubitemid 34495975)
27. Iwamatsu, A., and N. Yoshida-Kubomura. 1996. Systematic peptide fragmentation of polyvinylidene difluoride(PVDF)-immobilized proteins prior to microsequencing. J. Biochem. 120: 29-34. (Pubitemid 26258244)
28. Jo, D., D. Liu, S. Yao, R. D. Collins, and J. Hawiger. 2005. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat. Med. 11: 892-898.
29. Kahn, R. A., P. Randazzo, T. Serafini, O. Weiss, C. Rulka, J. Clark, M. Amherdt, P. Roller, L. Orci, and J. E. Rothman. 1992. The amino terminus of ADPribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport. J. Biol. Chem. 267: 13039-13046.
30. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
31. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
32. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNFalpha. Nature 381: 77-80.
33. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77. (Pubitemid 26130005)
34. Galli, S. J., M. Grimbaldeston, and M. Tsai. 2008. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 8: 478-486.
35. Shin, K., P. A. Nigrovic, J. Crish, E. Boilard, H. P. McNeil, K. S. Larabee, R. Adachi, M. F. Gurish, R. Gobezie, R. L. Stevens, and D. M. Lee. 2009. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J. Immunol. 182: 647-656.
36. Sun, J., G. K. Sukhova, P. J. Wolters, M. Yang, S. Kitamoto, P. Libby, L. A. MacFarlane, J. Mallen-St Clair, and G. P. Shi. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13: 719-724.
37. Klemm, S., J. Gutermuth, L. Hültner, T. Sparwasser, H. Behrendt, C. Peschel, T. W. Mak, T. Jakob, and J. Ruland. 2006. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J. Exp. Med. 203: 337-347.
38. Nishida, K., A. Hasegawa, S. Nakae, K. Oboki, H. Saito, S. Yamasaki, and T. Hirano. 2009. Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediate-type reaction. J. Exp. Med. 206: 1351-1364.
39. Engelman, J. A., J. Luo, and L. C. Cantley. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7: 606-619.
40. Lu-Kuo, J. M., D. A. Fruman, D. M. Joyal, L. C. Cantley, and H. R. Katz. 2000. Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products. J. Biol. Chem. 275: 6022-6029.
41. Fukao, T., T. Yamada, M. Tanabe, Y. Terauchi, T. Ota, T. Takayama, T. Asano, T. Takeuchi, T. Kadowaki, J. Hata Ji, and S. Koyasu. 2002. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3: 295-304.
42. Ali, K., A. Bilancio, M. Thomas, W. Pearce, A. M. Gilfillan, C. Tkaczyk, N. Kuehn, A. Gray, J. Giddings, E. Peskett, et al. 2004. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011. (Pubitemid 39434424)
43. Kim, M. S., M. Rådinger, and A. M. Gilfillan. 2008. The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol. 29: 493-501.
44. Marquardt, D. L., J. L. Alongi, and L. L. Walker. 1996. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production. J. Immunol. 156: 1942-1945.
45. Ishizuka, T., K. Chayama, K. Takeda, E. Hamelmann, N. Terada, G. M. Keller, G. L. Johnson, and E. W. Gelfand. 1999. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol. 162: 2087-2094.
46. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L. E. Samelson, J. J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3: 741-748.
47. Stearns, T., M. C. Willingham, D. Botstein, and R. A. Kahn. 1990. ADP-ribosylation factor is functionally and physically associated with the Golgi complex. Proc. Natl. Acad. Sci. USA 87: 1238-1242.
48. Cockcroft, S., G. Way, N. O'Luanaigh, R. Pardo, E. Sarri, and A. Fensome. 2002. Signalling role for ARF and phospholipase D in mast cell exocytosis stimulated by crosslinking of the high affinity FcepsilonR1 receptor. Mol. Immunol. 38: 1277-1282.
49. Gaynor, E. C., C. Y. Chen, S. D. Emr, and T. R. Graham. 1998. ARF is required for maintenance of yeast Golgi and endosome structure and function. Mol. Biol. Cell 9: 653-670.
50. Kanamarlapudi, V. 2005. Centaurin-alpha1 and KIF13B kinesin motor protein interaction in ARF6 signalling. Biochem. Soc. Trans. 33: 1279-1281.